Abstract
To say the least, the literature on indole hallucinogens and schizophrenia is confusing. This is because investigators who have access to schizophrenic patients do not have sophisticated gas chromatographic and mass spectrographic facilities, and those chemically sophisticated researchers who have such analytic facilities do not have access to a suitable patient research population. This situation has existed for some time and probably will continue to exist for a long time. The current nature of psychiatric research strategy, funding, social and legal pressures regarding informed consent and commitment of the mentally ill all combine to retard progress. This situation has become so confusing in the State of Michigan in the last two years that most research with mental patients has stopped. In attempting to protect the rights of the mentally ill, their rights to proper diagnoses and better treatments are being discarded.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams, R. L. P. Delayed methylation of DNA in developing sea urchin embryos. Nature (New Biol.), 1973, 244:131, 27–29.
Aghajanian, G. K., & Freedman, D. X. Biochemical and morphological aspects of LSD pharmacology. In D. H. Efron (Ed.), Psychopharmacology—A Review of Progress 1957–1967, PHSP #1836. Superintendent of Documents, Washington, D.C., 1968, pp. 1185-1193.
Aghajanian, G. K., Sheard, M. H., & Foote, W. E. LSD and mescaline: comparison of effects on single units in the midhrain raphé. In D. H. Efron (Ed.), Psychotomimetic Drugs, New York: Raven Press, 1970, pp. 165–170.
Ahn, H. A., Walker, R. W., VandenHeuvel, W. J. A., Rosegay, A., & Mandel, L. R. Studies on the in vivo biosynthesis of N, N-dimethyltryptamine (DMT) in the rabbit and rat. Fed. Proc. 1973, 32, 511.
Alexander, F., Curtis, G. C., III, Sprince, H. & Crosley, A. P., Jr. l-Methionine and l-tryptophan feedings in non-psychotic and schizophrenic patients with and without tranylcypromine. J. Nerv. Ment. Dis., 1963, 137, 135–142.
Appel, J. B. The effects of “psychotomimetic” drugs on animal behavior. In D. H. Efron (Ed.), Pharmacology—A Review of Progress 1957–1967, PHSP #1836, Superintendent of Documents, Washington, D.C., 1968, pp. 1211-1222.
Axelrod, J. The enzymatic N-methylation of serotonin and other amines. J. Pharmacol. Exp. Ther. 1962, 138, 28–33.
Ban, T. Monoamine oxidase inhibitor antidepressants, In Psychopharmacology. Baltimore: Williams and Wilkins, 1969.
Banarjee, S. P. & Snyder, S. H. Methyltetrahydrofolic acid mediates N- and O-methylation of biogenic amines. Science 1973, 182, 74–75.
Barchas, J. D., Elliott, G. R., DoAmaral, J., Erdelyi, E., O’Connor, S., Bowden, M., Brodie, H. K. H., Berger, P. A., Renson, J., & Wyatt, R. J. Triptolines: Formation from tryptamines and 5-MTHF by human platelets. Arch. Gen. Psychiat. 1974, 31, 862–867.
Bidder, T. G., Mandel, L. R., Ahn, H. S., Walker, R. W., & VandenHeuvel, W. J. A. Blood and urinary DMT concentrations in acute psychotic disorders. Lancet, 1974, 1, 165.
Bishop, P. O., Burke, W., & Hayhow, W. R. Lysergic acid diethylamide block of lateral geniculate synapses and relief by repetitive stimulation. Exp. Neurol. 1959, 1, 556–568.
Bishop, P. O., Field, G., Hennessy, B. L., & Smith, J. R. Actions of d-lysergic acid diethylamide on lateral geniculate synapses. J. Neurophysiol, 1958, 21, 529–549.
Borella, L., Herr, F., & Wojdan, A. Prolongation of certain effects of amphetamine by chlorpromazine. Canad. J. Physiol and Pharmacol., 1969, 47, 7–13.
Bovet, D., & Gatti, G. L. Pharmacology of instrumental avoidance conditioning. In Proceedings of 2nd International Pharmacological Meeting, Prague, 1965, pp. 75-89.
Caldwell, D. F., Oberleas, D., Clancy, J. J., & Praasad, A. A. Behavioral impairment in adult rats following acute zinc deficiency. Proc. Soc. Exp. Biol. Med., 1970, 133, 1417–1421.
Cohen, I. & Vogel, W. H. Determination and physiological disposition of dimethyltryptamine in rat brain, liver and plasma. Biochem. Pharmacol., 1972, 21, 1214–1218.
Coward, J. K., D’Urso-Scott, M.,& Sweet, W. D. Inhibition of catechol-O-methyltransferase by S-adenosylhomocysteine and S-adenosylhomocysteine sulfoxide, a potential transition-state analog. Biochem. Pharmacol., 1972, 21, 1200–1203.
Deguchi, T., & Barchas, J. Inhibitions of transmethylations of biogenic amines by S-adenosylhomocysteine. J. Biol. Chem., 1972. 246, 3175–3181.
Domino, E. F., Krause, R. R., & Bowers, J. Various enzymes involved with putative neuro-transmitters —regional distribution in the brain of deceased mentally normal, chronic schizophrenics or organic brain syndrome patients. Arch. Gen. Psychiat., 1973, 29, 195–201.
Domino, E. F., & Krause, R. R. Plasma tryptophan tolerance curves in drug free normal controls, schizophrenic patients and prisoner volunteers. J. Psychiat. Res., 1974a, 10, 247–261.
Domino, E. F., & Krause, R. R. Unpublished observations, 1974b.
Domino, E. F., & Luby, E. D. Abnormal mental states induced by phencyclidine as a model of schizophrenia. In J. O. Cole, A. Friedhoff, and A. M. Friedman (Eds.), Psychopathology and Psychopharmacology, Proc. 62 Meeting of Amer. Psychopath. Assoc., Baltimore: Johns Hopkins Press, 1973, pp. 35–50.
Domino, E. F., & Lutz, M. F. Unpublished observations, 1974.
Domino, E. F., & Sampath-Khanna, S. Decreased platelet MAO in chronic schizophrenics. Amer. J. Psychiat, 1975, in press.
Evarts, E. V. Effects of a series of indoles on synaptic transmission in the lateral geniculate nucleus of the cat. In H. H. Pennes (Ed.), Progress in Neurobiology, III-Psychopharmacology, New York, Hoeber-Harper, 1958, pp. 173-194.
Evarts, E. V., Landau, W., Freygang, W., Jr., & Marshall, W. H. Some effects of lysergic acid diethylamide and bufotenine on electrical activity in the cat’s visual system. Am. J. Physiol., 1955. 182, 594–598.
Fisher, R. Chemistry of the brain. Nature 1968, 220, 411.
Franzen, Fr., & Gross, H. Tryptamine, N, N-dimethyltryptamine, N, N-dimethyl-5-hydroxy-tryptamine and 5-methoxytryptamine in human blood and urine. Nature, 1965, 206, 1052.
Gillin, J. C., Cannon, E., Magyar, R., Schwartz, M., & Wyatt, R. J. Failure of DMT to evoke tolerance in cats. Biol. Psychiat., 1973, 7, 213–220.
Gilmour, D. C., Manowitz, P., Frosch, W. A., & Shopsin, B. Association of plasma tryptophan levels with clinical change in female schizophrenic patients. Biol. Psychiat., 1973, 6, 119.
Greenberg, R. N, N-Dimethylated and N, N-diethylated indoleamines in schizophrenia. In H. C. Sabelli (Ed.), Chemical Modulation of Brain Function—A tribute to J. E. P. Toman, New York, Raven Press, 1973, pp. 277–2
Gross, V. H., & Franzen, Fr. Zur bestimmung korpereigener amine in biologischen substraten. Zeitschrift für Klinische Chemie, 1965, 3, 99–102.
Heath, R. G., Vesselhof, W., Bishop, N. P., & Byers, L. W. Behavioral and metabolic changes associated with administration of tetraethylthiuram disulfide. Dis. Nerv. System 1965, 26, 99–106.
Himwich, H. E. (Ed.) Biochemistry, Schizophrenias and Affective Illnesses, Baltimore: Williams and Wilkins, 1971.
Himwich, H. E., Narashimhachari, N., Heller, B., Spaide, J., Haskovec, L., Fujimori, M., & Tabushi, K. Biochemical approaches to the study of schizophrenia. In H. C. Sabelli (Ed.), Chemical Modulations of Brain Function—A Tribute to J. E. P. Toman, New York: Raven Press, 1973.
Hoffer, A., Osmond, H., Callbeck, M. J., & Kahan, I. Treatment of schizophrenia with nicotinic acid and nicotinamide. J. Clin. Exp. Psychopath., 1957, 18, 131–158.
Holmstedt, B., & Lindgren, J. B. Chemical constituents and pharmacology of South American snuffs. In D. H. Efron (Ed.), Ethnopharmacologic Search for Psychoactive Drugs, Publication No. 1645, Public Health Service, Washington, D.C.,1967, pp. 339-382.
Horita, A., & Hamilton, A. E. Lysergic acid diethylamide: Dissociation of its behavioral and hyperthermic actions by DL-alpha-methyl-p-tyrosine. Science, 1969, 164, 78.
Hsu, L. L., & Mandell, A. J. Multiple N-methyltransferases for aromatic alkylamines in brain. Life Sci., 1973, 13, 847–868.
Isbell, H. Quoted in D. H. Efron (Ed.), Ethnopharmacologic Search for Psychoactive Drugs, Publication No. 1645, Public Health Service, Washington, D. C., 1967, p. 369.
Juntunen, J. M., Struck, W. G., Warner, K. A., Frohman, C. E., & Gottlieb, J. S. Effects of tryptophan loading on indole metabolite levels in blood and urine of schizophrenic patients. Biol. Psychiat., 1974, in press.
Kaplan, J., Mandel, L. R., Stillman, R., Walker, R. W., VandenHeuvel, W. J. A., Gillin, J. C. & Wyatt, R. J. Blood and urine levels of N, N-dimethyltryptamine following administration of psychoactive dosages to human subjects. Psychopharmacologia, 1974, 38, 239–245.
Kerr, S. J. Competing methyltransferase systems. J. Biol. Chem. 1972, 247, 4248–4252.
Koella, W. P. Neurophysiological effects of psychotomimetic substances (A supplemental review). In D. H. Efron (Ed.), Psychopharmacology—A Review of Progress 1957–1967, PHSP #1836, Superintendent of Documents, Washington, D.C., 1968, pp. 1223-1230.
Koella, W. P., Beaulieu, R. F., & Bergen, J. R. Stereotyped behavior and cyclic changes in response produced by LSD in goats. Int. J. Neuropharmacol., 1964, 3, 397–403.
Kovacic, B., & Domino, D. F. Effects of various drugs on DMT-induced disruption of rat bar pressing behavior. The Pharmacologist, 1973, 15, 218.
Kovacic, B. & Domino, E. F. Tolerance to behavioral effects of dimethyltryptamine (DMT) in the rat. Fed. Prod., 1974, 33, 549.
Krause, R. & Domino, E. F. Kinetics of product inhibition of rabbit lung N-methyltransferase. Res. Comm. Chem. Path. and Pharmacol. 1974, 9:2, 399–373.
Lal, S., & Sourkes, T. L. Effect of various chlorpromazine metabolites in amphetamine-induced stereotyped behavior in the rat. Europ. J. Pharmacol., 1972. 1 7, 283–286.
Lin, R. L., Narasimhachari, N., & Himwich, H. E. Inhibition of indolethylamine-N-methyl-transferase by S-adenosylhomocysteine. Biochem. Biophys. Res. Comm. 1973, 54, 751–759.
Lipinski, J., Mandel, L. R., Ahn, H. S., VandenHeuvel, W. J. A., & Walker, R. W. Blood dimethyltryptamine concentrations in psychotic disorders. Biol. Psychiat., 1974, 9:1, 89–91.
Lu, L. W., Wilson, A., Moore, R. H., & Domino, E. F. Correlation between brain N, N- dimethyltryptamine (DMT) levels and bar pressing behavior in rats: Effect of MAO inhibition. The Pharmacologist, 1974, 16, 237.
Mandel, L. R. Dimethyltryptamine: Its biosynthesis and possible role in mental disease. In E. F. Domino and J. M. Dau (Eds.), Neurotransmitters Balances Regulating Behavior. Ann Arbor, Michigan, Edwards Bros., Inc., 1975, in press.
Mandel, L. R., Rosegay, A., Walker, R. W., VandenHeuvel, W. J. A., & Rokach, J. 5-Methyl-tetrahydrofolate acid as a mediator in the formation of pyridoindoles. Science, 1974, 186, 741–743.
Mandel, L. R., Ahn, H. S., VandenHeuvel, W. J. A., & Walker, R. W. Indoleamine-N-methyl-transferase in human lung. Biochem. Pharmacol., 1972, 21, 1197–1200.
Mandel, L. R., Rosenzweig, S., & Kuehl, F. A., Jr. Purification and properties of indoleamine-N-methyltransferase. Biochem. Pharmacol., 1971, 20, 712–716.
Manowitz, P., Gilmour, D. G., & Racevskis, J. Low plasma tryptophan levels in recently hospitalized schizophrenics. Biol. Psychiat., 1973, 6, 109–118.
Martin, W. R., Sloan, J. W., Christian, S. T., & Clements, T. H. Brain levels of tryptamine. Psychopharmacologia (Berl.), 1972, 24, 331–346.
Moore, R. H., Demetriou, S., & Domino, E. F. Effects of iproniazid, chlorpromazine and methiothepin on DMT-induced changes in body temperature, pupil dilatation, blood pressure and EEG in the rabbit. Arch. Int. Pharmacol. et Dynamie., et de Ther., 1975, 213, 64–72.
Murphree, H. B., Dippy, R. H., Jenney, E. H., & Pfeiffer, C. C. Effects in normal man of α-methyltryptamine and α-ethyltryptamine. Clin Pharmacol. Ther., 1961, 2, 722–726.
Murphy, D. L., & Wyatt, R. J. Reduced monoamine oxidase activity in blood platelets from schizophrenic patients. Nature 1972, 238, 225–226.
Narasimhachari, N., Heller, B., Spaide, J., Haskovec, L., Fujimori, M., Tabushi, K., & Himwich, H. E. Urinary studies of schizophrenics and controls. Biol. Psychiat., 1971a, 3, 9–20.
Narasimhachari, N., Heller, B., Spaide, J., Haskovec, L., Meltzer, H., Strahilevitz, M., & Himwich, H. E. N-N-Dimethylated indoleamines in blood. Biol. Psychiat., 1971b. 3, 21–23.
Narasimhachari, N., Plaut, J. M., & Himwich, H. E. Indole ethylamine-N-methyltransferase in serum samples of schizophrenics and normal controls. Life Sci., 1972, 11, 221–227.
Rosenberg, D. E. Isbell, H., & Miner, E. J. Comparison of a placebo, N-dimethyltryptamine, and 6-hydroxy-N-dimethyltryptamine in man. Psychopharmacologia (Berl.), 1963, 4, 39–42.
Rosenberg, D. E., Isbell, H., Miner, E. J., & Logan, C. R. The effect of N, N-dimethyl-tryptamine in human subjects tolerant to lysergic acid diethylamide. Psychopharmacologia (Berl.), 1964, 5, 217–227.
Rosengarten, H., Szemis, A., Piotrowski, A., Romaszewska, K., Matsumato, H., Stencka, K., & Jus, A. N, N-Dimethyltryptamine and bufotenin in the urine of patients with chronic and acute schizophrenic psychoses. Psychiatria Polska, 1970, 4, 519–521.
Rothlin, E. Pharmacology of lysergic acid diethylamide and some of its related compounds. In S. Garattini and V. Ghetti (Eds.), Psychotropic Drugs, Amsterdam: Elsevier, 1957, pp. 36–47.
Saavedra, J. M., & Axelrod, J. Psychotomimetic N-methylated tryptamines: formation in brain in vivo and in vitro. Science, 1972, 172, 1365–1366.
Saavedra, J., Coyle, J. R., & Axelrod, J. The distribution and properties of the non-specific N-methyltransferase in brain. J. Neurochem., 1973, 20, 743–752.
Sai-Halász, A. The effect of antiserotonin on the experimental psychosis induced by dimethyltryptamine. Experentia (Basel), 1962a, 18, 137–138.
Sai-Halász, A. The role of serotonin antagonism in the model-psychoses. (Hung.) Iddeggyog-Szle, 1962b, 15, 301.
Sai-Halász, A. The effect of MAO inhibition on the experimental psychosis induced by dimethyltryptamine. Psychopharmacologia (Berl.), 1963, 4, 385–388.
Schwartz, M. A., Aikens, A. M., & Wyatt, R. J. Monoamine oxidase activity in brains from schizophrenic and mentally normal individuals. Psychopharmacologia, 1974, 38, 319–328.
Seevers, M. H., & Deneau, G. A. Physiological aspects of tolerance and physical dependence. In W. S. Root and F. G. Hofmann (Eds.), Physiological Pharmacology, Vol. 1, Part A, New York: Academic Press, 1963, pp. 565–640.
Shapiro, S. K., Almenas, A., & Thomson, J. F. Kinetics and mechanism of reaction of S-adenosylmethionine: homocysteine methyltransferase. J. Biol. Chem., 1965, 240, 2512–2518.
Smythies, J. R. (Ed.). The Mode of Action of Psychotomimetic Drugs. A Report Based On An NRP Work Session. Neurosciences Research Program Bulletin, 1970, 8, 1, 152.
Sourkes, T. L. Alpha-methyltryptophan and its actions on tryptophan metabolism. Fed. Proc, 1971, 30, 897–903.
Sprince, H., Parker, C. M., Jameson, D., & Alexander, F. Urinary indoles in schizophrenic and psychoneurotic patients after administration of tranylcypromine (Parnate) and methionine or tryptophan. J. Nerv. Ment. Dis., 1963, 137, 246–251.
Swiatek, K. R., Simon, L. N., & Chao, K.-L. Nicotinamide methyltransferase and S-adenosyl-methionine: 51-methylthioadenosine hydrolase. Control of transfer ribonucleic acid methylation. Biochem., 1973, 12, 4670–4674.
Szara, S. Hallucinogenic effects and metabolism of tryptamine derivatives in man. Fed. Proc., 1961, 20, 285–288.
Szara, S., & Axelrod, J. Hydroxylation and N-demethylation of N, N-dimethyltryptamine. Expenentia, 1959, 15, 216–217.
Szara, S., Hearst, E., & Putney, F. Metabolism and behavioral action of psychotropic tryptamine homologues. Int. J. Neuropharmacol., 1962, 1, 111–117.
Tedeschi, D. H., Tedeschi, R. E., & Fellows, E. J. The effects of tryptamine on the central nervous system, including a pharmacological procedure for the evaluation of iproniazid-like drugs. J. Pharmacol. Exp. Ther., 1959, 126, 223–232.
Tenen, S. S. An automated one-way avoidance box for the rat. Psychonom. Sci., 1965, 6, 407–408.
Vasko, M., Lutz, M. P., & Domino, E. F. Structure activity relations of some idolealkyamines in comparison to phenethylamines on motor activity and acquisition of avoidance behavior. Psychopharmacologia, 1974, 36, 49–58.
Walker, R. W., Ahn, H. S., Albers-Schonberg, G., Mandel, L. R., & VandenHeuvel, W. J. A. Gas chromatographic-mass spectrometric isotope dilution assay for N, N-dimethyltryptamine in human plasma. Biochem. Med., 1973, 8, 105–113.
Wise, C. D., Baden, M. M., & Stein, L. Postmortem measurement of enzymes in human brain: Evidence of a central noradrenergic deficit in schizophrenia. In E. F. Domino and J. Davis (Eds.), Neurotransmitter Balances Regulating Behavior, Ann Arbor, Michigan, Edwards Bros, Inc., 1975, in press.
Wyatt, R. J., Vaughan, T., Galanter, M., Kaplan, J., & Green, R. Behavioral changes of chronic schizophrenic patients given L-5 hydroxytryptophan. Science, 1972, 177, 1124–1126.
Wyatt, R. J., Mandel, L. R., Ahn, H. S., Walker, R. W. & VandenHeuvel, W. J. A. Gas chromatographic-mass spectrometric isotope dilution determination of N, N-dimethyltryptamine concentrations in normals and psychiatric patients. Psychopharmacologia (Berl.), 1973a, 31, 265-270.
Wyatt, R. J., Mandel, L. R., Ahn, H. S., Walker, R. W. & VandenHeuvel, W. J. A. DMT—a possible relationship to schizophrenia. Proc. 1st Intl. Serotonin Conference. 1973b, in press.
Wyatt, R. J., Murphy, D. L., Belmaker, R., Donnelly, D., Cohen, S., & Pollin, W. Reduced monoamine oxidase activity in platelets: a possible genetic marker for vulnerability to schizophrenia. Science, 1973c, 179, 916-918.
Wyatt, R. J., Saavedra, J. M., & Axelrod, J. A dimethyltrptamine (DMT) forming enzyme in human blood. Amer. J. Psychiat., 1973d, 130, 754–760.
Yang, H. Y. T., & Neff, N. H. The monoamine oxidases of brain: selective inhibition with drugs and the consequences of the metabolism of the biogenic amines. J. Pharmacol. Esp. Ther., 1974, 189, 3, 733–740.
Zappia, V., Zydek-Cwick, C. R., & Schlenk, F. The specificity of S-adenosylmethionine derivatives in methyl transfer reactions. J. Biol. Chem., 1969, 244, 4499–4509.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1976 Plenum Press, New York
About this chapter
Cite this chapter
Domino, E.F. (1976). Indole Hallucinogens as Animal Models of Schizophrenia. In: Serban, G., Kling, A. (eds) Animal Models in Human Psychobiology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-2184-2_14
Download citation
DOI: https://doi.org/10.1007/978-1-4684-2184-2_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-2186-6
Online ISBN: 978-1-4684-2184-2
eBook Packages: Springer Book Archive